Curcumin Modulates PTPRZ1 Activity and RNA m6A Modifications in Neuroinflammation-Associated Microglial Response.

Area of Science:

• Neuroscience
• Molecular Biology
• Pharmacology

Background:

• Neuroinflammation, driven by microglial hyperactivity, is implicated in various neurological disorders.
• Curcumin exhibits anti-inflammatory and antioxidant properties, showing potential in mitigating neuroinflammation.
• Understanding curcumin's molecular targets is crucial for developing effective neuroprotective therapies.

Purpose of the Study:

• To elucidate the molecular mechanisms by which curcumin modulates RNA post-transcriptional N(6)-methyladenosine (m6A) modification.
• To investigate curcumin's interaction with protein tyrosine phosphatase receptor Z1 (PTPRZ1) and its downstream effects.
• To determine how curcumin's action impacts microglial response and gene expression in neuroinflammation.

Main Methods:

• Investigating curcumin's effect on microglial activation in an epilepsy seizure model.
• Analyzing the interaction between curcumin, PTPRZ1, and YTHDF2 using molecular assays.
• Assessing changes in gene expression and inflammatory markers following curcumin treatment.

Main Results:

• Curcumin was found to interact with PTPRZ1, preserving its enzymatic activity.
• This interaction modulated the phosphorylation of the m6A-reader YTHDF2.
• The observed molecular changes led to reduced expression of inflammatory genes and mitigated microglial hyperactivity.

Conclusions:

• Curcumin exerts neuroprotective and anti-inflammatory effects by targeting RNA post-transcriptional m6A modification.
• The PTPRZ1-YTHDF2 pathway is a key molecular mechanism underlying curcumin's action.
• These findings offer novel therapeutic strategies for neuroinflammatory diseases.